Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Theradaptive
AddedFeb 15, 2024
UpdatedJun 18, 2026
Theradaptive

Theradaptive

Series A

Theradaptive, Inc.: A global pharmaceutical firm developing targeted tissue repair therapeutics via THX1 platform.

HQ
Frederick, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Theradaptive, Inc., founded with a mission to revolutionize tissue repair, leverages its proprietary THX1 platform to develop advanced therapeutics. The company's core vision is to create safer and more effective treatments by enhancing the targeted delivery of therapeutics, addressing significant unmet medical needs. Theradaptive focuses on global markets, offering innovative solutions that promote native tissue repair through advanced protein engineering.

Notable figures affiliated with Theradaptive include its pioneering scientists and strategic investors who support its groundbreaking research. The company has achieved significant milestones in therapeutic discovery, enhancing the efficacy and safety of protein-based treatments. Theradaptive's impact is evident in its potential to transform the pharmaceutical landscape by providing targeted, effective solutions for complex medical conditions.

Theradaptive - Similar Companies

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Therapyx logo

Therapyx

therapyxinc.com

Theracos logo

Theracos

theracos.com

Adaptive Phage Therapeutics logo

Adaptive Phage Therapeutics

Juvena Therapeutics logo

Juvena Therapeutics

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

Empirico logo

Empirico

empiricotx.com

Thesan Pharmaceuticals logo

Thesan Pharmaceuticals

thesanpharma.com

Theraly Pharmaceuticals logo

Theraly Pharmaceuticals

Therini Bio logo

Therini Bio

therinibio.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Guardian Therapeutics logo

Guardian Therapeutics

Theradaptive - Quick Facts

Who are Theradaptive's competitors?

Companies similar to Theradaptive include Neuraptive Therapeutics, Adcentrx Therapeutics, Therapyx and Theracos.

When was Theradaptive founded?

Theradaptive was founded in 2016.

Where is Theradaptive's headquarters located?

Theradaptive's headquarters is located in Frederick, MD, US.

When was Theradaptive's last funding round?

Theradaptive's most recent funding round was for $7.4M (USD) in September 2023.

How much has Theradaptive raised to-date?

As of Sep 26, 2023, Theradaptive has raised a total of $33.4M (USD).

How many employees does Theradaptive have?

Theradaptive has 23 employees as of Feb 4, 2024.

Theradaptive - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified